abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Company Response

11 Jan 2012

Author:
Abbott Laboratories

Abbott Laboratories statement regarding “Global Kaletra Campaign”

Abbott provides its HIV medicines at tiered prices for countries in greatest need and has put extensive measures in place to ensure access for those who need our medicines. This approach balances the needs of patients, countries’ levels of economic development, and our continued investment in the development and uninterrupted supply of quality anti-retroviral medicines.

Timeline